Literature DB >> 15692281

Gender differences in drug use and expenditures in a privately insured population of older adults.

Rosaly Correa-de-Araujo1, G Edward Miller, Jessica S Banthin, Yen Trinh.   

Abstract

We examine gender differences in use and expenditures for prescription drugs among Medicare and privately insured older adults aged 65 and over, using data on a nationally representative sample of prescription drug purchases collected for the Medical Expenditure Panel Survey Household Component. Overall, women spent about $1,178 for drugs, about 17% more than the $1,009 in average expenditures by men. Older women constituted 50.7% of the population and had average annual aggregate expenditures for prescribed medicines of $6.93 billion compared to $5.77 billion for men. Women were more likely than men to use drugs from a number of therapeutic classes-analgesics, hormones and psychotherapeutic agents-and therapeutic subclasses-thyroid drugs, COX-2 inhibitors and anti-depressants. Women also had higher average prescriptions per user for a number of therapeutic classes-hormones, psychotherapeutic agents and analgesics-and therapeutic subclasses-anti-diabetic drugs and beta blockers. Prescribed medications are, arguably, the most important healthcare technology in preventing illness, disability, and death in older adults. It is critical that older women and men have proper access to prescribed medicines. Given the financial vulnerability of this priority population, particularly women, the expanded drug coverage available under the Medicare Modernization Act is of particular relevance in meeting this goal.

Entities:  

Mesh:

Year:  2005        PMID: 15692281     DOI: 10.1089/jwh.2005.14.73

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  10 in total

1.  Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments.

Authors:  Kristin A Connors; Theodore W Valenti; Kelly Lawless; James Sackerman; Emmanuel S Onaivi; Bryan W Brooks; Georgianna G Gould
Journal:  Aquat Toxicol       Date:  2013-12-12       Impact factor: 4.964

2.  Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey.

Authors:  Jon Brännström; Katarina Hamberg; Lena Molander; Hugo Lövheim; Yngve Gustafson
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

3.  Prevalence and Socio-Demographic Determinants of Tobacco, Alcohol, Substance Use and Drug Misuse in General Population in Turkey.

Authors:  Mustafa Necmi Ilhan; Zehra Arikan; Zeynep Kotan; Tolga Tunçoğlu; Mustafa Pinarci; Ahmet Taşdemir; Bülent Ay; Nadir Koçak
Journal:  Noro Psikiyatr Ars       Date:  2016-02-15       Impact factor: 1.339

4.  Gender differences in aspirin use among adults with coronary heart disease in the United States.

Authors:  Alexander R Opotowsky; J Michael McWilliams; Christopher P Cannon
Journal:  J Gen Intern Med       Date:  2007-01       Impact factor: 5.128

5.  Persistent nonmalignant pain management using nonsteroidal anti-inflammatory drugs in older patients and use of inappropriate adjuvant medications.

Authors:  Nahid Rianon; Maureen E Knell; Walter Agbor-Bawa; Joan Thelen; Crystal Burkhardt; Rafia S Rasu
Journal:  Drug Healthc Patient Saf       Date:  2015-01-29

6.  Can gender difference in prescription drug use be explained by gender-related morbidity?: a study on a Swedish population during 2006.

Authors:  Jessica Skoog; Patrik Midlöv; Lars Borgquist; Jan Sundquist; Anders Halling
Journal:  BMC Public Health       Date:  2014-04-08       Impact factor: 3.295

7.  Drugs prescribed by general practitioners according to age, gender and socioeconomic status after adjustment for multimorbidity level.

Authors:  Jessica Skoog; Patrik Midlöv; Anders Beckman; Jan Sundquist; Anders Halling
Journal:  BMC Fam Pract       Date:  2014-11-25       Impact factor: 2.497

8.  Licit prescription drug use in a Swedish population according to age, gender and socioeconomic status after adjusting for level of multi-morbidity.

Authors:  Kristine Thorell; Jessica Skoog; Andrzej Zielinski; Lars Borgquist; Anders Halling
Journal:  BMC Public Health       Date:  2012-07-31       Impact factor: 3.295

9.  The prevalence of self-reported underuse of medications due to cost for the elderly: results from seven European urban communities.

Authors:  Aurima Stankuniene; Mindaugas Stankunas; Mark Avery; Jutta Lindert; Rita Mikalauskiene; Maria Gabriella Melchiorre; Francisco Torres-Gonzalez; Elisabeth Ioannidi-Kapolou; Henrique Barros; Arūnas Savickas; Raimondas Radziunas; Joaquim J F Soares
Journal:  BMC Health Serv Res       Date:  2015-09-26       Impact factor: 2.655

10.  Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century.

Authors:  Sarah Watson; Ola Caster; Paula A Rochon; Hester den Ruijter
Journal:  EClinicalMedicine       Date:  2019-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.